Document is current
Any future updates will be listed below
-
Authors
Falcone, Marco
Bao, Xiyu
Woodcock, Fionn
Di Virgilio, Roberto
Vidal Pereira, Maria Alejandra https://orcid.org/0000-0002-8038-3026
Kantecki, Michal https://orcid.org/0009-0001-9222-5295
Gheorghe, Maria https://orcid.org/0000-0002-4128-6063
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Accepted: 27 July 2025
First Online: 23 September 2025
Declarations
:
: This work was funded by Pfizer. Work by Source Health Economics was funded by Pfizer. Editorial and medical writing assistance was provided by Kelly O’Toole and Phillipa White, of Source Health Economics.
: Maria Gheorge, Roberto Di Virgilio, Maria Alejandra Vidal Pereira and Michal Kantecki are employees of Pfizer and hold stock options. Fionn Woodcock and Xiyu Bao are employees of Source Health Economics, a consultancy company that received funding from Pfizer to provide health economic and writing services for this project. Marco Falcone has received research grants from MSD, Gilead, and Menarini and participated in advisory boards or received speaker fees from Pfizer, Menarini, Thermo Fisher, Mundipharma and Shionogi.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
: Not applicable.
: Not applicable.
: All data generated or analysed during this study are included in this published article as supplementary information files.
: Not applicable.
: All authors: study concept and design, acquisition of data and critical revision of the manuscript. All authors have given approval to the final version of the manuscript. MG: analysis and interpretation of data, drafting of the manuscript, obtained funding, administrative, technical, or material support, and study supervision. XB and FW: analysis and interpretation of data, drafting of the manuscript and statistical analysis.
